We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Innospec's Q3 Earnings Beat Estimates on Chemicals Strength
Read MoreHide Full Article
Key Takeaways
Innospec's Q3 adjusted EPS rose 15.2% to $1.29, beating estimates by 2.4%.
Performance Chemicals operating income surged 83.7%, supported by favorable pricing and product mix.
Innospec ended the third quarter with $251.9 million in cash and cash equivalents and no debt.
Innospec Inc. (IOSP - Free Report) reported third-quarter 2026 adjusted earnings of $1.29 per share, up 15.2% from $1.12 a year ago. The figure topped the Zacks Consensus Estimate of $1.26 by 2.4%. Growth in Performance Chemicals and Oilfield Services operating income supported the results.
Revenues rose 7.2% year over year to $473.6 million but missed the consensus estimate of $479.2 million by 1.1%. All three businesses posted sales gains, with Oilfield Services recording the fastest growth at 13.4%.
Performance Chemicals revenues increased 5.7% year over year to $180.5 million. A favorable 12% contribution from pricing and product mix more than offset a 5% reduction in volumes and a 1% negative foreign currency impact. The sales mix helped cushion softer volumes.
The segment's gross margin expanded 3.7 percentage points to 18.8%. Operating income surged 83.7% to $16.9 million from $9.2 million. Management expects efficiency upgrades at its North Carolina plant to be commissioned by year-end, improving capacity, productivity and yields across personal care and other products.
Fuel Specialties sales climbed 5.1% year over year to $180.7 million. Volume growth of 3% combined with a 2% favorable price and product mix contribution. The segment continued to generate growth from both shipment activity and pricing.
Gross margin contracted 0.5 percentage points to 35.1%, although management noted that margins remained within its target range. Operating income edged up 0.8% to $35.6 million from $35.3 million. The relatively modest profit increase contrasted with stronger gains in the other two businesses, reflecting the segment's broadly steady performance.
IOSP's Oilfield Services Sales and Profit Advance
Oilfield Services revenues grew 13.4% year over year to $112.4 million. The business benefited from the recent expansion of its drag-reducing agent (DRA) plant, which supported higher operating income and improved operating margins.
Operating income advanced 39.6% to $6.7 million from $4.8 million. However, gross margin declined 1.8 percentage points to 28.2% due to a weaker sales mix. Sequential performance fell short of management's expectations because of continued activity delays in the legacy Middle East business and elevated raw material costs.
IOSP's Cash Flow and Debt-Free Balance Sheet
Cash provided by operating activities declined to $17.4 million from $39.1 million a year earlier. Capital spending was $15.6 million in the quarter, leaving limited cash generation after capital expenditures.
Management remains focused on improving working capital efficiency to support stronger operating cash flow.
Innospec ended the third quarter with $251.9 million in cash and cash equivalents and no debt.
Innospec's Outlook Centers on Operating Gains
Management expects Performance Chemicals to benefit from the North Carolina upgrades as utilization of added capacity improves and new-product development progresses. The company sees opportunities for further growth and margin improvement over the coming quarters, particularly in this business.
For Oilfield Services, management expects improvements in areas affected by delayed Middle East activity and elevated raw material costs to support sequential operating income growth in the fourth quarter. Fuel Specialties is expected to maintain consistent performance. Innospec continues to evaluate organic investment, acquisitions, dividends and share repurchases as uses of its balance-sheet flexibility.
IOSP’s Price Performance
IOSP’s shares have increased 6.9% over a year compared with the 18.4% growth recorded by the Zacks Chemicals Diversified industry.
Quaker Chemical Corporation (KWR - Free Report) reported third-quarter adjusted earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.16 by 10.6%. KWR expects fourth-quarter revenues and adjusted EBITDA to improve year over year but decline sequentially from third-quarter levels.
Huntsman Corporation (HUN - Free Report) reported third-quarter adjusted earnings of 4 cents per share. This compares with a loss of 3 cents in the year-ago quarter. Earnings missed the Zacks Consensus Estimate of 7 cents per share by 42.9%. HUN anticipates improved earnings and cash flow to reduce net debt leverage to approximately four times by year-end, supported by higher volumes, cost reductions and disciplined execution.
Olin Corporation (OLN - Free Report) logged third-quarter adjusted earnings of 14 cents per share, beating the Zacks Consensus Estimate of 10 cents by 40%. For the fourth quarter of 2026, OLN expects adjusted EBITDA between $80 million and $100 million.
View the Zacks #1 Rank List
Image: Bigstock
Innospec's Q3 Earnings Beat Estimates on Chemicals Strength
Key Takeaways
Innospec Inc. (IOSP - Free Report) reported third-quarter 2026 adjusted earnings of $1.29 per share, up 15.2% from $1.12 a year ago. The figure topped the Zacks Consensus Estimate of $1.26 by 2.4%. Growth in Performance Chemicals and Oilfield Services operating income supported the results.
Revenues rose 7.2% year over year to $473.6 million but missed the consensus estimate of $479.2 million by 1.1%. All three businesses posted sales gains, with Oilfield Services recording the fastest growth at 13.4%.
Innospec Inc. Price, Consensus and EPS Surprise
Innospec Inc. price-consensus-eps-surprise-chart | Innospec Inc. Quote
IOSP's Performance Chemicals Margin Improvement
Performance Chemicals revenues increased 5.7% year over year to $180.5 million. A favorable 12% contribution from pricing and product mix more than offset a 5% reduction in volumes and a 1% negative foreign currency impact. The sales mix helped cushion softer volumes.
The segment's gross margin expanded 3.7 percentage points to 18.8%. Operating income surged 83.7% to $16.9 million from $9.2 million. Management expects efficiency upgrades at its North Carolina plant to be commissioned by year-end, improving capacity, productivity and yields across personal care and other products.
Innospec's Fuel Specialties Delivers Steady Growth
Fuel Specialties sales climbed 5.1% year over year to $180.7 million. Volume growth of 3% combined with a 2% favorable price and product mix contribution. The segment continued to generate growth from both shipment activity and pricing.
Gross margin contracted 0.5 percentage points to 35.1%, although management noted that margins remained within its target range. Operating income edged up 0.8% to $35.6 million from $35.3 million. The relatively modest profit increase contrasted with stronger gains in the other two businesses, reflecting the segment's broadly steady performance.
IOSP's Oilfield Services Sales and Profit Advance
Oilfield Services revenues grew 13.4% year over year to $112.4 million. The business benefited from the recent expansion of its drag-reducing agent (DRA) plant, which supported higher operating income and improved operating margins.
Operating income advanced 39.6% to $6.7 million from $4.8 million. However, gross margin declined 1.8 percentage points to 28.2% due to a weaker sales mix. Sequential performance fell short of management's expectations because of continued activity delays in the legacy Middle East business and elevated raw material costs.
IOSP's Cash Flow and Debt-Free Balance Sheet
Cash provided by operating activities declined to $17.4 million from $39.1 million a year earlier. Capital spending was $15.6 million in the quarter, leaving limited cash generation after capital expenditures.
Management remains focused on improving working capital efficiency to support stronger operating cash flow.
Innospec ended the third quarter with $251.9 million in cash and cash equivalents and no debt.
Innospec's Outlook Centers on Operating Gains
Management expects Performance Chemicals to benefit from the North Carolina upgrades as utilization of added capacity improves and new-product development progresses. The company sees opportunities for further growth and margin improvement over the coming quarters, particularly in this business.
For Oilfield Services, management expects improvements in areas affected by delayed Middle East activity and elevated raw material costs to support sequential operating income growth in the fourth quarter. Fuel Specialties is expected to maintain consistent performance. Innospec continues to evaluate organic investment, acquisitions, dividends and share repurchases as uses of its balance-sheet flexibility.
IOSP’s Price Performance
IOSP’s shares have increased 6.9% over a year compared with the 18.4% growth recorded by the Zacks Chemicals Diversified industry.
Image Source: Zacks Investment Research
IOSP’s Zacks Rank & Other Chemical Releases
IOSP currently carries a Zacks Rank #5 (Strong Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Quaker Chemical Corporation (KWR - Free Report) reported third-quarter adjusted earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.16 by 10.6%. KWR expects fourth-quarter revenues and adjusted EBITDA to improve year over year but decline sequentially from third-quarter levels.
Huntsman Corporation (HUN - Free Report) reported third-quarter adjusted earnings of 4 cents per share. This compares with a loss of 3 cents in the year-ago quarter. Earnings missed the Zacks Consensus Estimate of 7 cents per share by 42.9%. HUN anticipates improved earnings and cash flow to reduce net debt leverage to approximately four times by year-end, supported by higher volumes, cost reductions and disciplined execution.
Olin Corporation (OLN - Free Report) logged third-quarter adjusted earnings of 14 cents per share, beating the Zacks Consensus Estimate of 10 cents by 40%. For the fourth quarter of 2026, OLN expects adjusted EBITDA between $80 million and $100 million.